Pharmacological and pharmacokinetic evaluation of celecoxib prodrugs in rats-Reference-Cited by-同舟云学术

Pharmacological and pharmacokinetic evaluation of celecoxib prodrugs in rats

Published:2002 Issue:7 Volume:23 Page:273-282
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Mamidi Rao N.V.S.,Mullangi Ramesh,Kota Jagannath,Bhamidipati Ravikanth,Khan Ansar A.,Katneni Kasiram,Datla Srinivasaraju,Singh Sunil K.,Rao Koteswar Y.,Seshagiri Rao C.,Srinivas Nuggehally R.,Rajagopalan Ramanujam

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Reference14 articles.

1. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.

2. Discovery and Design of Selective Cyclooxygenase-2 Inhibitors as Non-Ulcerogenic, Anti-Inflammatory Drugs with Potential Utility as Anti-Cancer Agents

3. The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis

4. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies to Improve the Transdermal Delivery of Poorly Water-Soluble Non-Steroidal Anti-Inflammatory Drugs;Pharmaceutics;2024-05-16

2. Nanoscale celecoxib prodrugs: As efficient anti-inflammatory principles;Journal of Drug Delivery Science and Technology;2023-12

3. Selenocoxib-3, a novel anti-inflammatory therapeutic effectively resolves colitis;Molecular and Cellular Biochemistry;2022-08-24

4. Celecoxib Loaded In-Situ Provesicular Powder and Its In-Vitro Cytotoxic Effect for Cancer Therapy: Fabrication, Characterization, Optimization and Pharmacokinetic Evaluation;Pharmaceutics;2020-11-28

5. Antinociception by fluoro-loxoprofen, a novel non-steroidal anti-inflammatory drug with less ulcerogenic effects, in rat models of inflammatory pain;European Journal of Pharmacology;2019-02